Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI

Clinical trial NCT06286059 · UNKNOWN

Trial details

NCT number: NCT06286059
Sponsor: Helwan University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

CA-AKI - Contrast-Associated Acute Kidney Injury Coronary Artery Disease Acute Coronary Syndrome Adrenergic Receptor Antagonist Adverse Reaction

Start date: 2024-03-07
Primary completion: 2024-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.